IP Library Granted Patent US 7,553,658
Granted Patent B2
US 7,553,658 · App. 10/526,089 · Granted Jun 30, 2009

Recovery of plasmids in an aqueous two-phase system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,553,658
App. No.
10/526,089
Granted
Jun 30, 2009
Kind
B2
Abstract

The present invention is a method for the purification of plasmid DNA comprising to provide a composition comprising a first polymer having inverse solubility characteristics and a second polymer immiscible in the first polymer; contacting said solution with an aqueous solution comprising plasmid DNA; providing phase separation and isolating the aqueous phase; and increasing the temperature of the isolated phase to a temperature above the cloud point of the first polymer and below the temperature where plasmid DNA is degraded and subsequently isolating the aqueous phase so formed. The invention also encompasses a kit for purification of plasmid DNA as described above.

Claims (12)

1. A method for the purification of plasmid DNA in an aqueous two-phase system, comprising:

(a) providing a composition including a first polymer EO 50 PO 50 , a second polymer Dextran T 500 and, optionally, a salt;

(b) contacting said composition with an aqueous solution comprising plasmid DNA and RNA to form a mixture which contains from about 4.5% (w/w) EO 50 PO 50 /4.5%(w/w) Dextran T 500, to about 2.5%(w/w)EO 50 PO 50 /9% (w/w) Dextran T 500;

(c) providing a phase separation wherein plasmid DNA is partitioned to a top aqueous phase while RNA partitions predominantly to a lower phase, and subsequently isolating the top aqueous phase;

(d) increasing the temperature of the isolated top aqueous phase to a temperature above the cloud point of the first polymer and below a temperature where plasmid DNA is degraded and subsequently isolating a top aqueous phase so formed; and, optionally,

(e) performing a chromatography step to recover the plasmid DNA from the isolated top phase of step (d).

2. The method of claim 1 , wherein the amount of the first polymer is about 4.5%(w/w) and the amount of the second polymer is about 4.5%(w/w) of the mixture in step (b).

3. The method of claim 1 , wherein the aqueous solution that includes plasmid DNA is a cell lysate, and wherein said method further comprises a step for desalting the cell lysate before step (b).

4. The method of claim 1 , wherein the contacting according to step (b) involves mixing at room temperature.

5. The method of claim 1 , wherein the isolation according to step (c) and/or step (d) is by centrifugation.

6. The method of claim 1 , wherein the salt concentration in said composition in step (a) is at least ten times above that of the aqueous solution.

7. The method of claim 2 , wherein the salt concentration in said composition in step (a) is at least ten times above that of the aqueous solution.

Assignments (2)
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2005
From: KEPKA, CECILIA; RHODIN, JENNY; TJERNELD, FOLKE
To: AMERSHAM BIOSCIENCES AB
Reel/Frame 015879/0270 →